Evidence map›Paper›PMID 40303266›Full record

Trial reportPediatric diabetes2023

Similar Perceptions on Continuous Glucose Monitor Use amongst Youth with Type 1 and Type 2 Diabetes.

Alexander Phu, Tyger Lin, Jacquelyn A Manfredo, Elizabeth A Brown, Risa M Wolf

2 registry-linked trialsAbstract readClinical Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Pediatric diabetes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04721145 nacompletednot on this map

IMPaCT: IMPlementing Continuous Glucose Monitoring in High-risk, Poorly Controlled Children With Type 1 Diabetes

TypeinterventionalSponsorJohns Hopkins UniversityRan2021 to 2022Enrolled26ConditionsType 1 Diabetes, Hypoglycemia, High Blood SugarArmsDexcom G6 Continuous Glucose Monitor
NCT04721158 nacompletednot on this map

IMPlementation of Continuous Glucose Monitoring in Children With Type 2 Diabetes

TypeinterventionalSponsorJohns Hopkins UniversityRan2021 to 2022Enrolled41ConditionsType 2 Diabetes, Hyperglycemia Due to Type 2 Diabetes MellitusArmsContinuous glucose monitor
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alexander PhuDepartment of Medicine, Kansas City University, Kansas City, USA.ORCID 0000-0002-3470-5450
Tyger LinDepartment of Pediatrics, Division of Endocrinology, Johns Hopkins University School of Medicine, Baltimore, USA.
Jacquelyn A ManfredoDepartment of Pediatrics, Division of Endocrinology, Johns Hopkins University School of Medicine, Baltimore, USA.
Elizabeth A BrownDepartment of Pediatrics, Division of Endocrinology, Johns Hopkins University School of Medicine, Baltimore, USA.
Risa M WolfDepartment of Pediatrics, Division of Endocrinology, Johns Hopkins University School of Medicine, Baltimore, USA.ORCID 0000-0001-7674-520X

Funding

Summer Program in Obesity, Diabetes and Nutrition Training (SPORT)T35DK095737 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI STEINLE, NANETTE I · 2012 to 2021
$859k
NIDDK NIH HHS T35 DK095737
6 · The paper itself

Abstract

Methods: Youth with T1D and T2D (currently on insulin therapy) without current CGM participated in a prospective CGM study and were given a series of questionnaires when starting CGM intervention. BenCGM and BurCGM questionnaires assessed the participant's perspectives on continuous glucose monitor use, while DDS surveys assessed participants' QoL associated with diabetes. Survey results were compared between T1D and T2D groups, and multivariable analysis was used to assess differences in perceptions of continuous glucose monitor use in youth with diabetes. Results: Participants with T1D ( Conclusions: Youth with T1D and T2D on insulin therapy report similar perspectives on continuous glucose monitor use and QoL measures. Insulin use in both T1D and T2D may carry a similar burden of management, and CGM may help improve quality of life. Trial registration: This trial is registered with NCT04721145, NCT04721158.

Indexed as

Blood Glucose Self-MonitoringDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2AdolescentBlood GlucoseChildFemaleGlycated HemoglobinHumansInsulinMalePerceptionProspective StudiesQuality of LifeSurveys and QuestionnairesYoung AdultBlood GlucoseGlycated HemoglobinInsulin

Identifiers

PMID40303266
PMCPMC12017215

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.